Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in kidney cancer

Glenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator brand- Reduces the risk of kidney cancer progression by 58%

Glenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator brand- Reduces the risk of kidney cancer progression by 58%

Read More

Cabozantinib most effective treatment for metastatic papillary kidney cancer: Study

Cabozantinib most effective treatment for metastatic papillary kidney cancer: Study

Read More